Skip to main content

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Main navigation

  • Schizophrenia Foundations
  • Symptomatology
  • Patient Burden
  • Caregiver Perspectives
  • Psychopharmacology

Psychopharmacology

Medication in hand
Can Peripherally Restricted Anticholinergics Like Trospium Reduce Risks?

Welcome to Schizophrenia Knowledge Base

This website is intended for healthcare professionals in the United States.

Yes, I am a US healthcare professional
No, I am not a US healthcare professional
Prescribing
End of the Anticholinergic Era? Rationale and Evidence-Based Strategies for Deprescribing
Research
CME: The Next Generation of Schizophrenia Treatment: Looking Beyond D2 and Exploring Novel Therapeutic Targets
Laboratory researcher
Overcoming Challenges in Schizophrenia Treatment
Neuron
New Mechanisms of Action in Psychiatry
Pharmacist
Developments in Treating Schizophrenia: New Mechanisms of Action and Methods of Delivery
Patient and provider
Innovative Pathways in Schizophrenia Treatment
Medication
Treatment Options and Managing Side Effects in Schizophrenia
Provider with medication
CME: Exploring Treatment Advances for Schizophrenia: Focus on the Patient Experience
Neuron
CME: Addressing the Core Issue: Presynaptic Modulation in Schizophrenia Using a Novel Class of Medication
Patient and provider
CME: How to Make Appropriate Treatment Decisions for Patients With Schizophrenia

Pagination

  • First page « First
  • Previous page ‹ Previous
  • Page 1
  • Page 2
  • Page 3
  • Current page 4
  • Page 5
  • Next page Next ›
  • Last page Last »
© 2025 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use Cookie Policy